Article
Absence of BRAF, NRAS, KRAS, HRAS mutations, and RET/PTC gene rearrangements distinguishes dominant nodules in Hashimoto thyroiditis from papillary thyroid carcinomas.
Endocrine pathology - 1 Jun 2010
Sadow Peter M, Heinrich Michael C, Corless Christopher L, Fletcher Jonathan A, Nosé Vânia
Abstract excerpt
Dominant nodules within Hashimoto thyroiditis (HT) may present with unique morphological features that overlap with but are not diagnostic of papillary thyroid carcinoma (PTC). Activating BRAF point mutations, RAS aberrations, and RET rearrangements are mutually exclusive events in the oncogenesis of papillary thyroid carcinoma, and RET rearrangements have been previously described in dominant nodules of HT. We...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.